Method of prolonging cancerous patient survival in humans with h

Details Method of prolonging cancerous patient survival in humans with h Method of prolonging cancerous patient survival in humans with h

1988-11-25

1989-09-19

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

Ammonia or ammonium compound containing

424709, A61K 3302

Patent

active

048679780

ABSTRACT:
Hydrazine sulfate, alone or formulated with liquid or solid carriers, will prolong patient survival when administered to early-stage human cancer patients parenterally or orally.

REFERENCES:
patent: 4110437 (1978-08-01), Gold

Affiliated with

Also associated with

Rating

Method of prolonging cancerous patient survival in humans with h does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of prolonging cancerous patient survival in humans with h, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of prolonging cancerous patient survival in humans with h will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-367680